1. Home
  2. GDTC vs PXLW Comparison

GDTC vs PXLW Comparison

Compare GDTC & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • PXLW
  • Stock Information
  • Founded
  • GDTC 2018
  • PXLW 1997
  • Country
  • GDTC Singapore
  • PXLW United States
  • Employees
  • GDTC N/A
  • PXLW N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • PXLW Semiconductors
  • Sector
  • GDTC Health Care
  • PXLW Technology
  • Exchange
  • GDTC Nasdaq
  • PXLW Nasdaq
  • Market Cap
  • GDTC 28.0M
  • PXLW 32.1M
  • IPO Year
  • GDTC 2023
  • PXLW 2000
  • Fundamental
  • Price
  • GDTC $2.04
  • PXLW $0.51
  • Analyst Decision
  • GDTC Buy
  • PXLW Strong Buy
  • Analyst Count
  • GDTC 1
  • PXLW 2
  • Target Price
  • GDTC $5.00
  • PXLW $1.25
  • AVG Volume (30 Days)
  • GDTC 9.2K
  • PXLW 267.8K
  • Earning Date
  • GDTC 01-01-0001
  • PXLW 05-13-2025
  • Dividend Yield
  • GDTC N/A
  • PXLW N/A
  • EPS Growth
  • GDTC N/A
  • PXLW N/A
  • EPS
  • GDTC N/A
  • PXLW N/A
  • Revenue
  • GDTC $368,838.00
  • PXLW $34,246,000.00
  • Revenue This Year
  • GDTC $5.37
  • PXLW $5.21
  • Revenue Next Year
  • GDTC N/A
  • PXLW $35.68
  • P/E Ratio
  • GDTC N/A
  • PXLW N/A
  • Revenue Growth
  • GDTC N/A
  • PXLW N/A
  • 52 Week Low
  • GDTC $1.20
  • PXLW $0.46
  • 52 Week High
  • GDTC $4.05
  • PXLW $1.18
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 38.29
  • PXLW 43.50
  • Support Level
  • GDTC $2.00
  • PXLW $0.46
  • Resistance Level
  • GDTC $2.45
  • PXLW $0.53
  • Average True Range (ATR)
  • GDTC 0.12
  • PXLW 0.02
  • MACD
  • GDTC -0.02
  • PXLW 0.00
  • Stochastic Oscillator
  • GDTC 4.46
  • PXLW 23.36

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About PXLW Pixelworks Inc.

Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.

Share on Social Networks: